Shareholding disclosure

Armistice Capital LLC

Declared position

3.75%

Threshold

Crossed upwards

Timeline

Published

01.10.2021

Transaction

23.09.2021

Voting rights breakdown

Voting rights acquired3.75%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAL9T00067

Beneficial owner

Armistice Capital LLC

Declared address

Armistice Capital, LLC, New York

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Armistice Capital LLC

Santhera Pharmaceuticals Holding AG01.10.2021TAL9T00067

Disclosure summary

Armistice Capital LLC disclosed a holding in Santhera Pharmaceuticals Holding AG on the acquisition side, published by SIX Exchange Regulation on 01.10.2021, at 3.75% of voting rights. Notice category: Single shareholder.

Disclosed position

3.75%

Voting rights acquired

Voting rights acquired3.75%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Armistice Capital LLC disclosed a holding in Santhera Pharmaceuticals Holding AG, published on 01.10.2021.

Publication date01.10.2021

Transaction date23.09.2021

Issuing companySanthera Pharmaceuticals Holding AG

Beneficial ownerArmistice Capital LLC

Declared addressArmistice Capital, LLC, New York

CategorySingle shareholder

Voting rights acquired3.75%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAL9T00067

Source: SIX Exchange Regulation · Publication date: 01.10.2021

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open